Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis
- Conditions
- Chronic Arsenic Poisoning
- Interventions
- Dietary Supplement: Garlic oil
- Registration Number
- NCT01748669
- Lead Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Brief Summary
Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed controls and healthy volunteers will be included for comparison.
- Detailed Description
Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition. Till today there is no effective treatment.
Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of this study is to examine the effectiveness of oral administration of garlic oil to reduce body arsenic load and clinical symptoms of arsenical palmer keratosis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Not provided
- pregnancy
- lactating mother
- patient receiving treatment of arsenicosis
- any other chronic disease like tuberculosis, diabetes mellitus, bronchial asthma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arsenic exposed controls Garlic oil One soft capsule of garlic oil (10 mg) daily for 12 weeks Patients of palmer arsenical keratosis Garlic oil One soft capsule of garlic oil (10 mg) daily for 12 weeks Heathy volunteers Garlic oil One soft capsule of garlic oil (10 mg) daily for 12 weeks
- Primary Outcome Measures
Name Time Method Change in the clinical symptom of keratosis in palm 0 week (baseline) to 12 weeks (end)
- Secondary Outcome Measures
Name Time Method Change in biochemical parameters (blood sugar, cholesterol and transaminase) after treatment 0 week (baseline), 12 weeks (end) Adverse effects following treament 0 week (baseline), 12 weeks (end) Change in the amount of arsenic in nail 0 week (baseline), 20 weeks (end)
Trial Locations
- Locations (1)
Bangabandhu Sheikh Mujib Medical University
🇧🇩Dhaka, Bangladesh